Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2013 - 2026)
Elite Pharmaceuticals' Return on Invested Capital [ROIC] was 29.21% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 41.48 percentage points from 70.69% a year earlier and down 13.00 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Invested Capital [ROIC] at Elite Pharmaceuticals came in at 49.40%, up 15.61 percentage points from FY2025.
- Return on Invested Capital [ROIC] has now increased for three consecutive fiscal years, with a four-year change of +26.51 percentage points (FY2022 to FY2026).
- In earlier fiscal years, Return on Invested Capital [ROIC] was 33.79% in FY2025 (+10.29 pp), 23.50% in FY2024 (+12.23 pp), 11.27% in FY2023 (-11.61 pp) and 22.88% in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q3 2025.
- Compared with a year earlier, Return on Invested Capital [ROIC] was higher in seven of the last eight quarters, with an average year-over-year change of +14.29 percentage points.
- The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was fiscal Q1 2026 (a gain of 49.12 percentage points); the worst was fiscal Q1 2027 (a drop of 41.48 percentage points).
- Per Business Quant data, ELTP's Return on Invested Capital [ROIC] in the three fiscal quarters before Q1 2027 was 42.21% (Q4 2026), 53.66% (Q3 2026) and 43.21% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 34.87% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 23.26% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 13.44% |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 29.19% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.19% |
| Mar 31, 2026 | 42.17% |
| Dec 31, 2025 | 53.59% |
| Sep 30, 2025 | 43.14% |
| Jun 30, 2025 | 70.54% |
| Mar 31, 2025 | 41.26% |
| Dec 31, 2024 | 27.38% |
| Sep 30, 2024 | 24.84% |
| Jun 30, 2024 | 21.53% |
| Mar 31, 2024 | 19.73% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 12.63% |
| Jun 30, 2023 | 11.62% |
| Mar 31, 2023 | 9.51% |
| Dec 31, 2022 | 11.21% |
| Sep 30, 2022 | 11.93% |
| Mar 31, 2022 | 19.87% |
| Dec 31, 2021 | 13.55% |
| Sep 30, 2021 | 10.88% |
| Dec 31, 2020 | 9.54% |
Elite Pharmaceuticals Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();